CA1055370A - Predicting and detecting ovulation - Google Patents
Predicting and detecting ovulationInfo
- Publication number
- CA1055370A CA1055370A CA238,645A CA238645A CA1055370A CA 1055370 A CA1055370 A CA 1055370A CA 238645 A CA238645 A CA 238645A CA 1055370 A CA1055370 A CA 1055370A
- Authority
- CA
- Canada
- Prior art keywords
- concentration
- lactic acid
- ovulation
- female
- organic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000016087 ovulation Effects 0.000 title claims abstract description 109
- 238000000034 method Methods 0.000 claims abstract description 73
- 210000003756 cervix mucus Anatomy 0.000 claims abstract description 42
- 239000012855 volatile organic compound Substances 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 16
- 238000012544 monitoring process Methods 0.000 claims abstract description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 184
- 239000004310 lactic acid Substances 0.000 claims description 92
- 235000014655 lactic acid Nutrition 0.000 claims description 92
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 78
- 241000124008 Mammalia Species 0.000 claims description 35
- 239000011230 binding agent Substances 0.000 claims description 29
- 230000028327 secretion Effects 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 150000002894 organic compounds Chemical class 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 230000004044 response Effects 0.000 claims description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 9
- 210000004914 menses Anatomy 0.000 claims description 8
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 6
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000011156 evaluation Methods 0.000 claims description 4
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 claims description 4
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical class CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 229940100595 phenylacetaldehyde Drugs 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims 6
- 238000007598 dipping method Methods 0.000 claims 4
- 101710088194 Dehydrogenase Proteins 0.000 claims 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- QQBPIHBUCMDKFG-UHFFFAOYSA-N phenazopyridine hydrochloride Chemical compound Cl.NC1=NC(N)=CC=C1N=NC1=CC=CC=C1 QQBPIHBUCMDKFG-UHFFFAOYSA-N 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 28
- 230000033764 rhythmic process Effects 0.000 abstract description 6
- 238000010998 test method Methods 0.000 abstract description 2
- 229960000448 lactic acid Drugs 0.000 description 68
- 229940011871 estrogen Drugs 0.000 description 31
- 239000000262 estrogen Substances 0.000 description 31
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 24
- 230000027758 ovulation cycle Effects 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 229940088597 hormone Drugs 0.000 description 14
- 239000005556 hormone Substances 0.000 description 14
- 230000036760 body temperature Effects 0.000 description 13
- 239000000186 progesterone Substances 0.000 description 12
- 229960003387 progesterone Drugs 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 9
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000029849 luteinization Effects 0.000 description 6
- 210000004681 ovum Anatomy 0.000 description 6
- 230000000624 ovulatory effect Effects 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000282560 Macaca mulatta Species 0.000 description 2
- 206010033314 Ovulation pain Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 229940093476 ethylene glycol Drugs 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000000938 luteal effect Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 229940095574 propionic acid Drugs 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 241000777300 Congiopodidae Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001610364 Ovula Species 0.000 description 1
- 206010064229 Pelvic discomfort Diseases 0.000 description 1
- 208000032749 Pregnancy Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical class C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007483 microbial process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000000136 postovulatory effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- -1 ~-methylbutyric acid Chemical compound 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0012—Ovulation-period determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D17/00—Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals
- A61D17/002—Devices for indicating trouble during labour of animals ; Methods or instruments for detecting pregnancy-related states of animals for detecting period of heat of animals, i.e. for detecting oestrus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B2010/0003—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
- A61B2010/0006—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements including means for analysis by an unskilled person involving a colour change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/906—Fertility tests
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
- Y10T436/201666—Carboxylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/519,220 US3986494A (en) | 1974-10-30 | 1974-10-30 | Method of predicting and detecting ovulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1055370A true CA1055370A (en) | 1979-05-29 |
Family
ID=24067389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA238,645A Expired CA1055370A (en) | 1974-10-30 | 1975-10-30 | Predicting and detecting ovulation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3986494A (enExample) |
| JP (1) | JPS5170994A (enExample) |
| AU (1) | AU8618975A (enExample) |
| CA (1) | CA1055370A (enExample) |
| DE (1) | DE2548638A1 (enExample) |
| FR (1) | FR2299005A1 (enExample) |
| ZA (1) | ZA756647B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12181462B2 (en) | 2019-07-25 | 2024-12-31 | Overture Life, Inc. | Identification of viable human embryos |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4334540A (en) * | 1979-05-01 | 1982-06-15 | Monell Chemical Senses Center | Method of diagnosing periodontal disease through the detection of pyridine compounds |
| US4385125A (en) * | 1980-11-14 | 1983-05-24 | Monell Chemical Senses Center | Method detecting ovulation by monitoring dodecanol concentration in saliva |
| US4390633A (en) * | 1981-07-24 | 1983-06-28 | The Curators Of The University Of Missouri | Determining reproductive status of mammals with NMR of cervical mucus |
| US4358288A (en) * | 1981-09-16 | 1982-11-09 | Goldman Dorothee F E | Fertility indicator system containing anthocyanin pigment |
| US4465077A (en) * | 1981-11-12 | 1984-08-14 | Howard Schneider | Apparatus and method of determining fertility status |
| US4467814A (en) * | 1982-03-19 | 1984-08-28 | Monell Chemical Senses Center | Method for detecting bovine estrus by determining methyl heptanol concentrations in vaginal secretions |
| US4534362A (en) * | 1982-05-07 | 1985-08-13 | University Patents, Inc. | Method and apparatus for detection of fertility |
| US5155045A (en) * | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
| US4931403A (en) * | 1985-01-25 | 1990-06-05 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
| US4670401A (en) * | 1985-01-25 | 1987-06-02 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
| US4879244A (en) * | 1985-01-25 | 1989-11-07 | Monell Chemical Senses Center | Birth control method involving monitoring of axillary androstenol and dehydroepiandrosterone |
| WO1990001304A1 (fr) * | 1988-07-29 | 1990-02-22 | Kabushiki Kaisha Semex Japan | Procede de diagnostic de maladies ovariennes et de grossesse chez les mammiferes et instrument destine a la mise en oeuvre de ce procede |
| GB9217808D0 (en) * | 1992-08-21 | 1992-10-07 | Unilever Plc | Advisory method |
| GB9217864D0 (en) * | 1992-08-21 | 1992-10-07 | Unilever Plc | Monitoring method |
| AU759245B2 (en) * | 1992-08-21 | 2003-04-10 | Inverness Medical Switzerland Gmbh | Monitoring method |
| GB9217865D0 (en) | 1992-08-21 | 1992-10-07 | Unilever Plc | Monitoring method |
| US7141212B2 (en) | 1993-11-12 | 2006-11-28 | Inverness Medical Switzerland Gmbh | Reading devices and assay devices for use therewith |
| US6451619B1 (en) | 1994-06-29 | 2002-09-17 | Inverness Medical Switzerland Gmbh | Monitoring methods and devices for use therein |
| US6927064B1 (en) * | 1994-06-29 | 2005-08-09 | Inverness Medical Switzerland Gmbh | Fertility computing method |
| US5721142A (en) * | 1994-08-22 | 1998-02-24 | Texas A & M University System | Method for monitoring mammalian reproductive cycles |
| US5762614A (en) * | 1994-08-25 | 1998-06-09 | Caillouette; James C. | Estrogen or estradiol need determination by vaginal acidity determination |
| US5725481A (en) | 1996-05-17 | 1998-03-10 | A. Fem Medical Corporation | Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes |
| ATE213333T1 (de) * | 1996-09-27 | 2002-02-15 | Unilever Nv | Überwachungsverfahren |
| DE69626016T2 (de) * | 1996-09-27 | 2004-01-08 | Inverness Medical Switzerland Gmbh | Test-Kit und Vorrichtungen |
| US6479015B1 (en) | 1998-03-03 | 2002-11-12 | Pepex Biomedical, Llc | Apparatus for monitoring a level of a chemical species in a body fluid |
| GB9807134D0 (en) | 1998-04-02 | 1998-06-03 | Unilever Plc | Test methods devices and test kits |
| WO2012125650A1 (en) | 2011-03-14 | 2012-09-20 | Valley Electronics Llc | Portable preprogrammed thermometer for indicating fertility status |
| WO2018077998A1 (en) * | 2016-10-27 | 2018-05-03 | Ava Ag | System and a method for non-invasive monitoring of estrogen |
| EP3335638A1 (en) | 2016-12-13 | 2018-06-20 | Colorimetrix GmbH | Method and device for estimation of ovulation date |
| WO2019008970A1 (ja) * | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| CN110537097B (zh) * | 2017-07-07 | 2022-03-08 | 松下知识产权经营株式会社 | 信息提供方法、信息处理系统、信息终端及信息处理方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037496A (en) * | 1959-08-03 | 1962-06-05 | Frederick J Melges | Fertility testing apparatus |
| US3406016A (en) * | 1965-02-01 | 1968-10-15 | Raymond O. Foster | Means for detecting the fertile period |
| US3406015A (en) * | 1965-02-01 | 1968-10-15 | Raymond O. Foster | Means for detecting the fertile period |
| US3472738A (en) * | 1967-06-12 | 1969-10-14 | Weston Lab Inc | Test implement for detecting peroxidase |
| US3842166A (en) * | 1973-02-05 | 1974-10-15 | Microbyx Corp | Method and device for testing for the presence of micro-organisms |
-
1974
- 1974-10-30 US US05/519,220 patent/US3986494A/en not_active Expired - Lifetime
-
1975
- 1975-10-22 ZA ZA00756647A patent/ZA756647B/xx unknown
- 1975-10-30 DE DE19752548638 patent/DE2548638A1/de active Pending
- 1975-10-30 JP JP50129968A patent/JPS5170994A/ja active Pending
- 1975-10-30 CA CA238,645A patent/CA1055370A/en not_active Expired
- 1975-10-30 AU AU86189/75A patent/AU8618975A/en not_active Expired
- 1975-10-30 FR FR7533147A patent/FR2299005A1/fr active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12181462B2 (en) | 2019-07-25 | 2024-12-31 | Overture Life, Inc. | Identification of viable human embryos |
Also Published As
| Publication number | Publication date |
|---|---|
| AU8618975A (en) | 1977-05-05 |
| FR2299005B1 (enExample) | 1979-01-12 |
| ZA756647B (en) | 1976-09-29 |
| JPS5170994A (enExample) | 1976-06-19 |
| FR2299005A1 (fr) | 1976-08-27 |
| US3986494A (en) | 1976-10-19 |
| DE2548638A1 (de) | 1976-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1055370A (en) | Predicting and detecting ovulation | |
| US4010738A (en) | Method of predicting and detecting ovulation | |
| US4119089A (en) | Method of predicting and determining ovulation by monitoring the concentration of volatile sulfur-containing compounds present in mouth air | |
| US4670401A (en) | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators | |
| EP0385621B1 (en) | Method and apparatus for monitoring the ovulation cycle | |
| JP2761291B2 (ja) | モニタ装置 | |
| AU2006307604B2 (en) | Ovulation cycle monitoring and management | |
| US4036212A (en) | Method of predetermining time of ovulation in women and in animals to control conception | |
| JP3149111B2 (ja) | 避妊の目的で排卵周期の状態を監視する方法 | |
| US6403380B1 (en) | Ovulation cycle monitoring methods | |
| US4931403A (en) | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators | |
| Templeton et al. | Relation between the luteinizing hormone peak, the nadir of the basal body temperature and the cervical mucus score | |
| MXPA97001240A (en) | Methods of cont | |
| Syrop et al. | Diurnal variations in midluteal serum progesterone measurements | |
| US5914271A (en) | Fertility test | |
| CN1129898A (zh) | 用于检测排卵的方法、装置以及测试盒 | |
| Schramm et al. | Determination of free progesterone in an ultrafiltrate of saliva collected in situ | |
| Ismail et al. | An evaluation of the Bioself 110 fertility indicator | |
| AU2002237407B2 (en) | Improvements in or relating to assessment of fertility | |
| US4879244A (en) | Birth control method involving monitoring of axillary androstenol and dehydroepiandrosterone | |
| Paz et al. | Determination of urinary luteinizing hormone for prediction of ovulation | |
| Wan | Simple method for assay of luteinizing hormone in urine | |
| Umapathysivam et al. | A rapid RIA for LH in serum and first morning void urine—application in an AID programme | |
| Collins et al. | Biochemical methods for predicting ovulation | |
| CN1178098A (zh) | 监测方法 |